Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.07M Buy
75,315
+17,008
+29% +$1.13M 0.01% 618
2026
Q1
$3.66M Buy
58,307
+36
+0.1% +$2.51K ﹤0.01% 683
2025
Q4
$3.87M Sell
58,271
-2,271
-4% -$147K ﹤0.01% 675
2025
Q3
$4.07M Buy
60,542
+10,334
+21% +$818K ﹤0.01% 665
2025
Q2
$4.38M Sell
50,208
-6,381
-11% -$500K 0.01% 635
2025
Q1
$3.86M Sell
56,589
-3,429
-6% -$280K 0.01% 641
2024
Q4
$4.67M Buy
60,018
+14,513
+32% +$1.07M 0.01% 605
2024
Q3
$3.05M Sell
45,505
-50,621
-53% -$4.16M ﹤0.01% 717
2024
Q2
$10.9M Buy
96,126
+4,051
+4% +$512K 0.01% 404
2024
Q1
$12.8M Sell
92,075
-3,434
-4% -$432K 0.02% 382
2023
Q4
$11.9M Buy
95,509
+18,987
+25% +$1.94M 0.02% 386
2023
Q3
$7.14M Sell
76,522
-4,142
-5% -$467K 0.01% 465
2023
Q2
$10.4M Sell
80,664
-7,163
-8% -$866K 0.02% 397
2023
Q1
$10.2M Sell
87,827
-272
-0.3% -$30.4K 0.02% 398
2022
Q4
$9.98M Sell
88,099
-4,334
-5% -$476K 0.02% 405
2022
Q3
$7.45M Sell
92,433
-4,603
-5% -$390K 0.02% 422
2022
Q2
$7.23M Sell
97,036
-7,412
-7% -$676K 0.01% 441
2022
Q1
$13.4M Sell
104,448
-368
-0.4% -$40.3K 0.02% 359
2021
Q4
$14.1M Buy
104,816
+776
+0.7% +$112K 0.02% 361
2021
Q3
$14.2M Sell
104,040
-964
-0.9% -$122K 0.03% 335
2021
Q2
$11.2M Buy
105,004
+10,696
+11% +$1.03M 0.02% 375
2021
Q1
$8.47M Buy
94,308
+6,956
+8% +$653K 0.02% 431
2020
Q4
$8.07M Buy
87,352
+3,492
+4% +$312K 0.02% 426
2020
Q3
$8.64M Sell
83,860
-8,304
-9% -$868K 0.02% 381
2020
Q2
$9.34M Sell
92,164
-11,468
-11% -$1.03M 0.02% 366
2020
Q1
$6.98M Sell
103,632
-18,636
-15% -$1.16M 0.02% 378
2019
Q4
$6.68M Buy
122,268
+2,220
+2% +$105K 0.02% 436
2019
Q3
$4.48M Buy
120,048
+9,304
+8% +$361K 0.01% 532
2019
Q2
$4.15M Sell
110,744
-940
-0.8% -$29.5K 0.01% 558
2019
Q1
$3.33M Sell
111,684
-34,208
-23% -$1.2M 0.01% 601
2018
Q4
$4.37M Buy
145,892
+5,252
+4% +$167K 0.01% 493
2018
Q3
$5.03M Sell
140,640
-36,328
-21% -$1.13M 0.01% 508
2018
Q2
$4.2M Buy
176,968
+16,744
+10% +$355K 0.01% 550
2018
Q1
$2.97M Buy
160,224
+51,760
+48% +$765K 0.01% 655
2017
Q4
$1.56M Sell
108,464
-16,856
-13% -$219K ﹤0.01% 892
2017
Q3
$1.53M Buy
125,320
+42,728
+52% +$755K ﹤0.01% 896
2017
Q2
$1.51M Buy
82,592
+24,436
+42% +$451K 0.01% 882
2017
Q1
$1.23M Sell
58,156
-15,536
-21% -$303K ﹤0.01% 977
2016
Q4
$1.1M Buy
73,692
+33,172
+82% +$588K ﹤0.01% 1022
2016
Q3
$888K Buy
40,520
+20,748
+105% +$462K ﹤0.01% 1089
2016
Q2
$392K Buy
19,772
+4,244
+27% +$72.3K ﹤0.01% 1411
2016
Q1
$264K Sell
15,528
-9,272
-37% -$155K ﹤0.01% 1569
2015
Q4
$508K Buy
24,800
+5,448
+28% +$113K ﹤0.01% 1289
2015
Q3
$415K Sell
19,352
-8,960
-32% -$200K ﹤0.01% 1380
2015
Q2
$566K Buy
28,312
+2,196
+8% +$38.6K ﹤0.01% 1298
2015
Q1
$407K Sell
26,116
-1,096
-4% -$16.6K ﹤0.01% 1449
2014
Q4
$374K Sell
27,212
-392
-1% -$4.8K ﹤0.01% 1486
2014
Q3
$276K Buy
27,604
+3,656
+15% +$37.4K ﹤0.01% 1608
2014
Q2
$238K Buy
23,948
+22,040
+1,155% +$195K ﹤0.01% 1712
2014
Q1
$20K Sell
1,908
-1,592
-45% -$16.5K ﹤0.01% 2839
2013
Q4
$31K Buy
3,500
+2,700
+338% +$21.4K ﹤0.01% 2605
2013
Q3
$6K Buy
+800
New +$5.07K ﹤0.01% 2992

Other funds holding DXCM

US Bancorp's DXCM Position: Q2 2026 in Review

US Bancorp increased its DexCom (DXCM) stake by 29% in Q2 2026, buying an estimated $1.13M and bringing the position to 75,315 shares worth $5.07M. The position accounts for 0.01% of the portfolio, ranked #618.

US Bancorp first reported a position in DXCM in Q3 2013 and has held it in 52 quarters since. The position peaked at $14.2M in Q3 2021. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • US Bancorp held 75,315 shares of DexCom worth $5.07M as of Q2 2026.
  • US Bancorp bought 17,008 DexCom shares in Q2 2026, an estimated $1.13M.
  • DexCom made up 0.01% of US Bancorp's portfolio in Q2 2026, its #618 holding.
  • US Bancorp first reported a position in DexCom in Q3 2013 and has held it in 52 quarters since.
  • US Bancorp's DexCom position peaked at $14.2M in Q3 2021.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.